Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.97%
|
$10,000
$2.94 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,760
-1.32%
|
$109,480
$23.86 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,828
+2.86%
|
$104,140
$5.42 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,156
-1.67%
|
$95,588
$23.86 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,321
+3.08%
|
$90,963
$3.33 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.6%
|
$506,000
$23.91 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.54%
|
$132,000
$6.45 P/Share
|
|
Dec 14
2020
|
Hung Do Chief Science Officer |
SELL
Open market or private sale
|
Direct |
111,125
-21.34%
|
$2,555,875
$23.88 P/Share
|
|
Dec 01
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.75%
|
$34,500
$23.5 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,783
-6.82%
|
$545,226
$22.77 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,783
+6.38%
|
$49,566
$2.52 P/Share
|
|
Dec 01
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.9%
|
$165,000
$22.77 P/Share
|
|
Dec 01
2020
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
8,837
+50.0%
|
-
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,931
-25.71%
|
$118,620
$20.0 P/Share
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,931
+10.85%
|
$71,172
$12.46 P/Share
|
|
Nov 02
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,782
-6.82%
|
$421,294
$17.87 P/Share
|
|
Nov 02
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,782
+6.38%
|
$49,564
$2.52 P/Share
|
|
Nov 02
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
33,875
-3.92%
|
$575,875
$17.87 P/Share
|
|
Nov 02
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
23,975
+2.7%
|
$119,875
$5.96 P/Share
|
|
Nov 02
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.9%
|
$27,000
$18.01 P/Share
|
|
Oct 09
2020
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,510
-3.76%
|
$82,650
$15.12 P/Share
|
|
Oct 09
2020
|
Hung Do Chief Science Officer |
SELL
Open market or private sale
|
Direct |
193,700
-27.11%
|
$2,905,500
$15.03 P/Share
|
|
Oct 09
2020
|
Hung Do Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
193,700
+9.06%
|
$1,743,300
$9.97 P/Share
|
|
Oct 02
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+4.8%
|
$22,000
$2.45 P/Share
|
|
Oct 01
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.36%
|
$70,000
$14.02 P/Share
|
|
Oct 01
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.3%
|
$10,000
$2.94 P/Share
|
|
Oct 01
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
29,900
-3.43%
|
$418,600
$14.02 P/Share
|
|
Oct 01
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.25%
|
$100,000
$5.96 P/Share
|
|
Oct 01
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+4.06%
|
$21,000
$14.28 P/Share
|
|
Sep 30
2020
|
Jay Barth Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,064
-2.43%
|
$56,896
$14.51 P/Share
|
|
Sep 30
2020
|
Jay Barth Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,064
+2.37%
|
$8,128
$2.29 P/Share
|
|
Sep 28
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,782
-6.82%
|
$322,166
$13.89 P/Share
|
|
Sep 28
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,782
+6.38%
|
$49,564
$2.52 P/Share
|
|
Aug 17
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,181
+31.67%
|
-
|
|
Apr 15
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,673
+19.89%
|
-
|
|
Oct 03
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.14%
|
$360,000
$12.69 P/Share
|
|
Sep 24
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.1%
|
$240,000
$12.45 P/Share
|
|
Sep 21
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.24%
|
$600,000
$12.53 P/Share
|
|
Sep 13
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.48%
|
$1,100,000
$11.74 P/Share
|
|
Sep 12
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+2.38%
|
$6,000,000
$12.0 P/Share
|
|
Mar 05
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
335,827
+1.79%
|
$4,365,751
$13.56 P/Share
|
|
Mar 02
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.55%
|
$1,300,000
$13.89 P/Share
|
|
Mar 01
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.55%
|
$1,300,000
$13.69 P/Share
|